| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1857-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1757-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1757-SP | |||
| Carrier Free | MAB1757-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3508-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1857-SP | |||
| Carrier Free | MAB1857-500 | |||
![N/A Lipocalin-2/NGAL [Biotin]](http://images.novusbio.com/fullsize2/DATA_Lipocalin2_DY1857_ELISA_2306.jpg "N/A Lipocalin-2/NGAL [Biotin]")
![N/A Lipocalin-2/NGAL [HRP]](http://images.novusbio.com/fullsize2/DATA_Lipocalin2_DLCN20_ELISA_742.jpg "N/A Lipocalin-2/NGAL [HRP]")
![N/A Lipocalin-2/NGAL [HRP]](http://images.novusbio.com/fullsize2/Lipocalin-2_DLCN20_ELISA_131.jpg)
![N/A Lipocalin-2/NGAL [HRP]](http://images.novusbio.com/fullsize2/DATA_Lipocalin2_MLCN20_ELISA_995.jpg "N/A Lipocalin-2/NGAL [HRP]")
![N/A Lipocalin-2/NGAL [HRP]](http://images.novusbio.com/fullsize2/Lipocalin-2_MLCN20_ELISA_285.jpg)
![LCN2 promotes resistance to gemcitabine and angiogenesis.Effect of gemcitabine on the growth of tumors formed by (A) BxPC3-NS and –LCN2KD2 cell lines and (B) with PANC1-EV and –LCN2 cell lines [*denotes significance between vehicle treated cell lines (n = 10 per group, p<0.0001, mixed model multiple regression) †denotes significance between vehicle and gemcitabine treated mice injected with BxPC3 LCN2KD2 (n = 10 per group, p = 0.0003, mixed model multiple regression)]. (C) Protein lysates isolated from BxPC3 and PANC1 xenografts were assayed for caspase-3 cleavage after gemcitabine treatment (n = 10). (D) Representative histological images of xenografts formed by BxPC3 NS and –LCN2KD2, and PANC1-EV and –LCN2 cells after H&E, and immunostaining for LCN2, Ki67, and murine CD31. (E) Vascular density in five hot spots at high magnification in the BxPC3 NS and –LCN2KD2, and PANC1-EV and –LCN2 xenografts. The mRNA expression of (F) HIF1A and (G) VEGF in the BxPC3 and PANC1 xenografts. Gene expression was compared between KD and NS, or LCN2 and EV. [*denotes significance between KD and NS, or LCN2 and EV (n = 20; p<0.05, student t-test)]. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23056397), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/af1757_human-mouse-rat-lipocalin-2-ngal-affinity-pur-polyclonal-ab-812025555342.jpg)
![N/A Lipocalin-2/NGAL [Biotin]](http://images.novusbio.com/fullsize2/DATA_Lipocalin2_DY1757_ELISA_1711.jpg "N/A Lipocalin-2/NGAL [Biotin]")
![N/A Lipocalin-2/NGAL [Biotin]](http://images.novusbio.com/fullsize2/DATA_Lipocalin2_DY3508_ELISA_1953.jpg "N/A Lipocalin-2/NGAL [Biotin]")
